Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.

Das, Santa Kumar; Ranabhat, Kamal; Bhattarai, Suraj; Karki, Khem Bahadur; Gyanwali, Pradip; Paneru, Hem Raj; Nepal, Bipin; Dumre, Shyam Prakash; Acharya, Subhash Prasad

Das, Santa Kumar; Ranabhat, Kamal; Bhattarai, Suraj; Karki, Khem Bahadur; Gyanwali, Pradip; Paneru, Hem Raj; Nepal, Bipin; Dumre, Shyam Prakash; Acharya, Subhash Prasad.

Afiliação

Das SK; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Ranabhat K; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Bhattarai S; Ministry of Health and Population Kathmandu Nepal.
Karki KB; Global Institute for Interdisciplinary Studies Kathmandu Nepal.
Gyanwali P; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Paneru HR; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Nepal B; Institute of Medicine Tribhuvan University Teaching Hospital Kathmandu Nepal.
Dumre SP; Grande International Hospital Kathmandu Nepal.
Acharya SP; Central Department of Microbiology Tribhuvan University Kathmandu Nepal.

Clin Case Rep ; 9(4): 2132-2137, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33821192

Palavras-chave

COVID19 infection; Nepal; convalescent plasma therapy; multimorbidity

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2021 Tipo de documento: Article